Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02792647Phase 1Completed
Phase 1, randomised, double-blind trial in premature ejaculation (PE) comparing Placebo with IX-01 (2 arms). Primary endpoint: Number of Participants with One or More Drug Related Adverse Events (AEs) or any Serious AEs. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02792647.